Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
80.84
-0.35 (-0.43%)
At close: Apr 7, 2026, 4:00 PM EDT
82.34
+1.50 (1.86%)
Pre-market: Apr 8, 2026, 8:01 AM EDT
Edwards Lifesciences Revenue
In the year 2025, Edwards Lifesciences had annual revenue of $6.07B with 11.55% growth. Edwards Lifesciences had revenue of $1.57B in the quarter ending December 31, 2025, with 13.26% growth.
Revenue (ttm)
$6.07B
Revenue Growth
+11.55%
P/S Ratio
7.68
Revenue / Employee
$379,225
Employees
16,000
Market Cap
46.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.07B | 628.10M | 11.55% |
| Dec 31, 2024 | 5.44B | 429.50M | 8.57% |
| Dec 31, 2023 | 5.01B | 546.00M | 12.23% |
| Dec 31, 2022 | 4.46B | -768.50M | -14.69% |
| Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
| Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
| Dec 31, 2019 | 4.35B | 625.20M | 16.79% |
| Dec 31, 2018 | 3.72B | 287.50M | 8.37% |
| Dec 31, 2017 | 3.44B | 471.60M | 15.91% |
| Dec 31, 2016 | 2.96B | 470.00M | 18.85% |
| Dec 31, 2015 | 2.49B | 170.80M | 7.35% |
| Dec 31, 2014 | 2.32B | 277.40M | 13.56% |
| Dec 31, 2013 | 2.05B | 145.90M | 7.68% |
| Dec 31, 2012 | 1.90B | 221.00M | 13.17% |
| Dec 31, 2011 | 1.68B | 231.60M | 16.01% |
| Dec 31, 2010 | 1.45B | 125.60M | 9.51% |
| Dec 31, 2009 | 1.32B | 83.70M | 6.76% |
| Dec 31, 2008 | 1.24B | 146.60M | 13.44% |
| Dec 31, 2007 | 1.09B | 54.10M | 5.22% |
| Dec 31, 2006 | 1.04B | 39.10M | 3.92% |
| Dec 31, 2005 | 997.90M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medtronic | 35.48B |
| Stryker | 25.12B |
| Koninklijke Philips | 20.94B |
| GE HealthCare Technologies | 20.63B |
| Boston Scientific | 20.07B |
| Zimmer Biomet Holdings | 8.23B |
| Smith & Nephew | 6.16B |
| STERIS | 5.83B |
EW News
- 8 days ago - Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits - Business Wire
- 5 weeks ago - Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose - Business Wire
- 6 weeks ago - Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences - Business Wire
- 7 weeks ago - Edwards Lifesciences scraps anti-copycat policy, EU drops antitrust investigation - Reuters
- 7 weeks ago - Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day - Business Wire
- 7 weeks ago - Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 2 months ago - Edwards Lifesciences forecasts 2026 profit above estimates on heart devices strength - Reuters
- 2 months ago - Edwards Lifesciences Reports Fourth Quarter Results - Business Wire